Pilot Study of Bevacizumab (Avastin) in Patients With Septic Shock

Summary

The purpose of this study is to perform a pilot study to assess the potential use of Bevacizumab (a vascular endothelial growth factor (VEGF) inhibitor) in sepsis.

Timeline

Start

2010-02

Primary completion

2015-01

Completion

2015-01

Publications

• Shapiro NI, Aird WC. Sepsis and the broken endothelium. Crit Care. 2011 Mar 21;15(2):135. doi: 10.1186/cc10044.

Drugs

Indications